New blood test could boost IVF success for women with repeated failure
NCT ID NCT07363018
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a simple blood test measuring miRNA levels can predict the best time to transfer an embryo during IVF. About 546 women with unexplained recurrent implantation failure will be randomly assigned to either standard embryo transfer or transfer timed based on the blood test results. The goal is to see if personalized timing improves pregnancy rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- peripheral blood miRNA analysis
- What this could lead to
- If successful, this blood test could help doctors time embryo transfers more precisely, potentially increasing pregnancy rates for women with recurrent implantation failure.
- What could go wrong
- This is an early-stage trial with no prior proof of benefit. The test may not improve outcomes, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT IMPLANTATION FAILURE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a traditional chinese herb boost IVF success?
- Could a blood spin help women with failed IVF get pregnant?
- New study probes hidden uterine clues behind repeated miscarriages and IVF failure
- Blood protein may hold key to unexplained miscarriages and IVF failures
- Stem cell mobilization offers new hope for uterine scarring and infertility